CAS: 342026-92-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Sipoglitazar REF: TR-S487800CAS: 342026-92-0 | - - - | 293.00 €~1,928.00 € | Fri 22 Nov 24 |
 | Sipoglitazar REF: 3D-FS145116CAS: 342026-92-0 | Min. 95% | To inquire | Fri 27 Dec 24 |
 | Sipoglitazar REF: TM-T28783CAS: 342026-92-0 | 98% | 1,090.00 €~2,888.00 € | Tue 14 Jan 25 |
Sipoglitazar
Controlled ProductCAS:342026-92-0
Applications Sipoglitazar is a novel antidiabetic agent. Sipoglitazar displays triple agonistic activities on the human …
Formula:
C25H25N3O4S
Color and Shape:
Neat
Molecular weight:
463.55
Ref: TR-S487800
| 5mg | 1,928.00 € | ||
| 500µg | 293.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
Sipoglitazar
CAS:342026-92-0
Sipoglitazar is an antidiabetic agent that is used in the treatment of type 2 diabetes. …
Formula:
C25H25N3O4S
Purity:
Min. 95%
Molecular weight:
463.55 g/mol
Ref: 3D-FS145116
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
Sipoglitazar
CAS:342026-92-0
Sipoglitazar, a PPARγ agonist, is used potentially for the treatment of diabetes.
Formula:
C25H25N3O4S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
463.55
Ref: TM-T28783
| 25mg | 1,688.00 € | ||
| 50mg | 2,217.00 € | ||
| 100mg | 2,888.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
